X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
TTK HEALTHCARE LIMITED Fact Sheet - Equitymaster
Investing in India? Get Equitymaster Research  

TTK HEALTHCARE LIMITED  (TTKP)


Here is the latest financial fact sheet of TTK HEALTHCARE. For more details, see the TTK HEALTHCARE quarterly results and TTK HEALTHCARE share price and chart. For a sector overview, read our pharmaceuticals sector report.
 
ttk healthcare - 1 Year Stock Price Chart
Loading...

 Price History
    Price Rs 779.0       No. of shares m 7.77
    Mkt Cap Rs m 6,053       % ch % -0.5
    Vol '000 0.2       % ch week % -1.4
    P/E X 30.7       % ch 1-mth % 0.0
    P/CF X 38.9       % ch 12-mth % -18.9
    EPS (TTM) Rs 25.3       52 week H/L Rs 1,110.0/770.0
(As on Apr 26, 2017 01:28:00 PM) »  Best Performing pharmaceuticals Stocks

Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!
 Financials

* Results Consolidated
No. of Months
Year Ending
12
Mar-10
12
Mar-11
12
Mar-12
12
Mar-13
12
Mar-14
5-Yr Chart
Click to enlarge
  EQUITY SHARE DATA
High Rs304473681598663 
Low Rs95255350330399 
Sales per share (Unadj.) Rs327.5400.2455.3492.0535.6 
Earnings per share (Unadj.) Rs11.819.020.118.315.9 
Diluted earnings per shareRs11.719.020.118.315.9 
Cash flow per share (Unadj.) Rs14.221.523.221.820.0 
Dividends per share (Unadj.) Rs3.504.004.004.004.00 
Adj. dividends per shareRs3.474.004.004.004.00 
Dividend yield (eoy) %1.81.10.80.90.8 
Book value per share (Unadj.) Rs84.097.5112.9126.4137.6 
Adj. book value per shareRs83.397.5112.9126.4137.6 
Shares outstanding (eoy) m7.707.777.777.777.77 
Bonus/Rights/Conversions  BB---- 
Price / Sales ratio x0.60.91.10.91.0 
Avg P/E ratio x16.919.225.625.433.3 
P/CF ratio (eoy) x14.116.922.321.326.5 
Price / Book Value ratio x2.43.74.63.73.9 
Dividend payout %29.621.119.921.925.1 
Avg Mkt Cap Rs m1,5362,8284,0053,6074,127 
No. of employees `0001.31.51.51.81.7 
Total wages/salary Rs m302368436530607 
Avg. sales/employee Rs Th1,877.92,103.72,336.52,175.92,436.7 
Avg. wages/employee Rs Th224.9249.1287.7301.4355.2 
Avg. net profit/employee Rs Th67.899.7103.280.872.5 
  INCOME DATA
Net Sales Rs m2,5223,1093,5373,8234,162 
Other income Rs m3844476761 
Total revenues Rs m2,5603,1533,5843,8904,223 
Gross profit Rs m152214238201197 
Depreciation Rs m1820242732 
Interest Rs m1717262530 
Profit before tax Rs m155222236216197 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m6474797473 
Profit after tax Rs m91147156142124 
Gross profit margin %6.06.96.75.34.7 
Effective tax rate %41.333.533.634.337.0 
Net profit margin %3.64.74.43.73.0 
  BALANCE SHEET DATA
Current assets Rs m1,1591,4821,4611,5441,629 
Current liabilities Rs m7351,0779439991,058 
Net working cap to sales %16.813.014.614.313.7 
Current ratio x1.61.41.51.51.5 
Inventory Days Days3331342630 
Debtors Days Days3338393434 
Net fixed assets Rs m303374393438556 
Share capital Rs m7878787878 
"Free" reserves Rs m454565685791878 
Net worth Rs m6477578779821,069 
Long term debt Rs m0656159 
Total assets Rs m1,5441,9291,9242,0942,399 
Interest coverage x10.113.910.29.57.6 
Debt to equity ratio x00000.1 
Sales to assets ratio x1.61.61.81.81.7 
Return on assets %7.08.59.58.06.4 
Return on equity %14.119.517.814.511.6 
Return on capital %26.631.329.624.518.5 
Exports to sales %0.70.70.71.20.8 
Imports to sales %2.11.00.91.21.4 
Exports (fob) Rs m1721264733 
Imports (cif) Rs m5432324758 
Fx inflow Rs m1721264733 
Fx outflow Rs m5636375163 
Net fx Rs m-39-15-11-4-30 
  CASH FLOW
From Operations Rs m 190 254 62 244 127 
From Investments Rs m -112 -71 -43 -5 -146 
From Financial Activity Rs m -88 -68 -9 -20 22 
Net Cashflow Rs m -9 115 10 218 3 
* Results Consolidated Source: Company Annual Reports, Regulatory Filings, Equitymaster »  Historical quarterly results for ttk healthcare limited

 Share Holding
Indian Promoters : 65.4%
Foreign collaborators : 0.0%
Indian inst/Mut Fund : 3.7%
FIIs : 5.2%
ADR/GDR : 0.0%
Free float : 25.8%
Shareholders : 12,723
Pledged promoter(s) holding : 0.0%
 Company Information
Top
    REGD OFF: No.6, Cathedral Road, Chennai - 600 086
    E-MAIL: skr@ttkhealthcare.com     WEB: www.ttkhealthcare.com
    TELEPHONE: (044) 2811 6106     FAX: (044) 2811 6387
    SECTOR: PHARMACEUTICALS     GROUP: MISCELLANEOUS
    TR AGENT: Data Software, 19, Pycrofts Garden Road, Nungambakkam, Chennai-06
    AUDITOR: Aiyar & Co.
CHM: T. T. Jagannathan COMP SEC: S. Kalyanaraman YEAR OF INC: 1958 BSE CODE: 507747 FV (Rs): 10 DIV YIELD (%): 0.5

More pharmaceuticals Company Fact Sheets:   CADILA HEALTHCAREAMAR REMEDIESTORRENT PHARMAELDER PHARMAALKEM LABORATORIES


Today's Market

Sensex Touches Record High; FMCG Stocks Witness Buying(11:30 am)

After opening the day on a positive note, Indian share markets have continued their momentum and are presently trading in the green.

Views on news

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

Glenmark: Zetia Generics Boost Growth (Quarterly Results Update - Detailed)

Feb 15, 2017

Glenmark has announced its 3QFY16 results. The company has reported 41% YoY growth in net sales and 143.2% YoY increase in net profits. Here is our analysis of the results.

Sun Pharma: USFDA Observations Post Good Quarterly Performance (Quarterly Results Update - Detailed)

Dec 12, 2016

Sun Pharma has announced its September quarter (2QFY17) results. The company has reported 13.2% YoY growth in sales and a growth of 117% in the net profits. Here is our analysis of the results.

More Views on News

Most Popular

Our Private Class with India's Value Investing Guru(The 5 Minute Wrapup)

Apr 19, 2017

Rohan and Kunal present you the discussions with professor Sanjay Bakshi in his virtual classroom.

HDFC Bank: The Solid Outperformer(Chart Of The Day)

Apr 22, 2017

Why HDFC Bank beat the Sensex by nearly 3 times.

Aur Bhi Dukh Hain Zamane Main Stock Market Ke Siva...(Vivek Kaul's Diary)

Apr 13, 2017

The link between the Indian economy and the stock market is weak, and the stock market is not a reflection of the Indian economy.

The Real Reason Indiabulls Real Estate Jumped 42%(Daily Profit Hunter)

Apr 19, 2017

An elephant and six blind men will tell you more about the markets than any financial newspaper or channel.

7 Benefits Of Creating A CAN(Outside View)

Apr 13, 2017

The MFU platform offers ease, convenience, and speed of transacting in various mutual fund schemes.

More

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - MYLAN COMPARISON

Compare Company With Charts

COMPARE TTK HEALTHCARE WITH

MARKET STATS